Showing results (81-90 of 89) with videos related to
Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 89 results.
JACC. Cardiovascular Interventions|April 24, 2025
Relationships of hsCRP to High-Risk Vulnerable Plaque After NSTEMI: Insights From the PROSPECT II TrialOle Fröbert, Gregg W Stone, Alf Inge Larsen, et al.The New England Journal of Medicine|August 31, 2016
Drug-Eluting or Bare-Metal Stents for Coronary Artery DiseaseKaare H Bønaa, Jan Mannsverk, Rune Wiseth, et al.Journal of the American College of Cardiology|May 28, 2025
Lipoprotein(a), Cholesterol, Triglyceride Levels, and Vulnerable Coronary Plaques: A PROSPECT II SubstudyDavid Erlinge, Sotirios Tsimikas, Michael Maeng, et al.Lancet (London, England)|March 14, 2021
Identification of vulnerable plaques and patients by intracoronary near-infrared spectroscopy and ultrasound (PROSPECT II): a prospective natural history studyDavid Erlinge, Akiko Maehara, Ori Ben-Yehuda, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|June 25, 2026
Linking Lipidomics to Vulnerable Coronary Plaques: A PROSPECT II SubstudyTania Sharma, Tove Fall, Sergi Sayols-Baixeras, et al.Circulation|January 14, 2017
High-Intensity Interval Training in Patients With Heart Failure With Reduced Ejection FractionØyvind Ellingsen, Martin Halle, Viviane Conraads, et al.European Heart Journal|September 3, 2014
Effect of intravenous TRO40303 as an adjunct to primary percutaneous coronary intervention for acute ST-elevation myocardial infarction: MITOCARE study resultsDan Atar, Håkan Arheden, Alain Berdeaux, et al.European Heart Journal|April 22, 2017
Intracoronary autologous bone marrow cell transfer after myocardial infarction: the BOOST-2 randomised placebo-controlled clinical trialKai C Wollert, Gerd P Meyer, Jochen Müller-Ehmsen, et al.The New England Journal of Medicine|September 1, 2025
Beta-Blockers after Myocardial Infarction in Patients without Heart FailureJohn Munkhaugen, Anna Meta D Kristensen, Sigrun Halvorsen, et al.Pageof 9